Literature DB >> 25204345

Association of mutation patterns in GyrA and ParC genes with quinolone resistance levels in lactic acid bacteria.

Shaoying Li1, Zhen Li1, Wan Wei2, Chunyan Ma1, Xiaomin Song1, Shufen Li3, Wenying He4, Jianjun Tian1, Xiaoyan Huo1.   

Abstract

The quinolone resistance of 19 lactic acid bacterial strains belonging to the genera Enterococcus and Lactobacillus isolated from the natural fermented koumiss and yoghurt were investigated. The objective of this study was to determine the quinolone resistance levels and to explore the association of the resistance with the mutation patterns in gyrA and parC genes, as is currently recommended by the Food and Agriculture Organization/World Health Organization Joint Expert Committee in Guidelines for Evaluation of Probiotics in Food for probiotic lactic acid bacteria drug resistance in 2001. The Oxford Cup method and double-tube dilution method were used to determine the quinolone resistance levels of the isolated strains. Generally, all of the 19 strains showed resistance towards norfloxacin and ciprofloxacin when the Oxford cup method was used, whereas the incidence was lower (to norfloxacin 89.5% and to ciprofloxacin 68.4%) when minimum inhibitory concentration breakpoints (CLSI M100-S23) were tested. Furthermore, gene sequencing was conducted on gyrA and parC of topoisomerase II of these isolated strains. The genetic basis for quinolone resistance may be closely related to mutations in gyrA genes as there were 10 mutation sites in amino-acid sequences encoded by gyrA genes in 10 quinolone resistance strains and 14 mutation sites in Enterococcus durans HZ28, whereas no typical mutations were detected in parC genes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25204345     DOI: 10.1038/ja.2014.113

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  30 in total

Review 1.  The lactic acid bacteria: a literature survey.

Authors:  Frank J Carr; Don Chill; Nino Maida
Journal:  Crit Rev Microbiol       Date:  2002       Impact factor: 7.624

Review 2.  Enterococci as emerging pathogens of humans.

Authors:  D Morrison; N Woodford; B Cookson
Journal:  Soc Appl Bacteriol Symp Ser       Date:  1997

3.  Antibiotic resistance patterns of enterococci and occurrence of vancomycin-resistant enterococci in raw minced beef and pork in Germany.

Authors:  G Klein; A Pack; G Reuter
Journal:  Appl Environ Microbiol       Date:  1998-05       Impact factor: 4.792

4.  Methods in DNA replication.

Authors:  Marcel Méchali
Journal:  Methods       Date:  2012-06       Impact factor: 3.608

Review 5.  Management of infections due to resistant enterococci: a review of therapeutic options.

Authors:  D Landman; J M Quale
Journal:  J Antimicrob Chemother       Date:  1997-08       Impact factor: 5.790

6.  Antibiotic susceptibility profiles of new probiotic Lactobacillus and Bifidobacterium strains.

Authors:  J S Zhou; C J Pillidge; P K Gopal; H S Gill
Journal:  Int J Food Microbiol       Date:  2005-02-01       Impact factor: 5.277

Review 7.  Mechanisms of action and resistance of older and newer fluoroquinolones.

Authors:  D C Hooper
Journal:  Clin Infect Dis       Date:  2000-08       Impact factor: 9.079

Review 8.  Enterococci acquire new kinds of resistance.

Authors:  R Leclercq
Journal:  Clin Infect Dis       Date:  1997-01       Impact factor: 9.079

9.  First Streptococcus agalactiae isolates highly resistant to quinolones, with point mutations in gyrA and parC.

Authors:  Yoshiaki Kawamura; Hiromitsu Fujiwara; Noriko Mishima; Yuko Tanaka; Ayako Tanimoto; Shiro Ikawa; Youko Itoh; Takayuki Ezaki
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

10.  Characterization of the quinolone resistant determining regions in clinical isolates of pneumococci collected in Canada.

Authors:  Samir N Patel; Roberto Melano; Allison McGeer; Karen Green; Donald E Low
Journal:  Ann Clin Microbiol Antimicrob       Date:  2010-01-18       Impact factor: 3.944

View more
  2 in total

1.  Antibiotic Resistance of LACTOBACILLUS Strains.

Authors:  Elizaveta A Anisimova; Dina R Yarullina
Journal:  Curr Microbiol       Date:  2019-09-25       Impact factor: 2.188

2.  Assessing the drug resistance profiles of oral probiotic lozenges.

Authors:  Yi Wang; Jingya Dong; Junyi Wang; Wei Chi; Wei Zhou; Qiwen Tian; Yue Hong; Xuan Zhou; Hailv Ye; Xuechen Tian; Rongdang Hu; Aloysius Wong
Journal:  J Oral Microbiol       Date:  2022-01-07       Impact factor: 5.474

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.